TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT03055221 · COMPLETED

Trial details

NCT number: NCT03055221
Sponsor: United Therapeutics
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2005-06-10
Primary completion: 2014-02-25
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.